首页|可溶性生长刺激表达基因2蛋白联合N末端B型利钠肽原对急诊经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者预后的预测价值

可溶性生长刺激表达基因2蛋白联合N末端B型利钠肽原对急诊经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者预后的预测价值

扫码查看
目的:探讨可溶性生长刺激表达基因 2 蛋白(sST2)联合N末端B型利钠肽原(NT-proBNP)对急诊经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者预后的预测价值.方法:收集 2020 年 8 月至 2021 年 2 月在辽宁省人民医院首次确诊STEMI并行急诊PCI的患者 206 例.根据是否在随访期内发生主要不良心血管事件(MACE,包括心原性死亡、脑卒中、心力衰竭及缺血驱动的血运重建的复合终点事件)分为MACE组和非MACE组.采用Cox回归分析STEMI患者急诊PCI后发生MACE的独立危险因素,并采用ROC曲线评估sST2 和NT-proBNP对STEMI患者急诊PCI后发生MACE的预测价值,并用Delong检验分析单用sST2 或NT-proBNP及sST2 联合NT-proBNP的预测效能.结果:随访 3 年,共发生MACE 62 例.与非MACE组比较,MACE组患者sST2、NT-proBNP水平均较高,左前降支病变、前壁心肌梗死患者比例较高,LVEF较低,冠状动脉慢血流比例较大(P均<0.05).多因素Cox回归分析显示,sST2(HR=1.018,95%CI:1.012~1.024,P<0.001)和NT-proBNP(HR=1.001,95%CI:1.000~1.010,P<0.001)均是MACE的独立预测因素.根据ROC曲线和Delong检验分析显示,sST2联合NT-proBNP预测MACE的AUC为0.854,灵敏度为 64.5%,特异度为 93.1%,sST2 联合NT-proBNP预测MACE的效能优于单用sST2 或NT-proBNP(Z=2.119,P=0.034;Z=2.178,P=0.029).结论:sST2、NT-proBNP是预测STEMI患者急诊PCI后发生MACE的有效指标,且二者联合预测效能更佳.
Prognostic Value of Soluble ST2 Combined With NT-proBNP in ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Objectives:To investigate the prognostic value of soluble growth stimulation expressed gene 2 protein(sST2)combined with N-terminal pro-brain natriuretic peptide(NT-proBNP)in patients with ST-segment elevation myocardial infarction(STEMI)undergoing primary percutaneous coronary intervention(PCI).Methods:A total of 206 patients who were diagnosed with STEMI for the first time and underwent emergency PCI from August 2020 to February 2021 in the People's Hospital of Liaoning Province were enrolled.Patients were followed up for 3 years and divided into major adverse cardiac event(MACE,a composite endpoint event including cardiac death,stroke,heart failure,and ischemia-driven revascularization)group and MACE-free group.Multivariate cox analysis was performed to determine the independent risk factors for the prognosis of primary PCI in STEMI patients;the predictive value of sST2 and NT-proBNP for the occurrence of MACE in STEMI patients undergoing primary PCI was assessed by ROC analysis and the prediction of MACE by each factor by itself and the combined variables was analyzed with the Delong test.Results:There were 62 cases of MACE during the 3-year follow-up.Compared with the MACE-free group,patients in the MACE group had higher levels of sST2 and NT-proBNP,higher proportion of patients with left anterior descending branch lesions,anterior wall myocardial infarction,lower LVEF,and higher proportion of coronary artery slow flow(all P<0.05).Multivariate Cox analysis showed that sST2(HR=1.018,95%CI:1.012-1.024,P<0.001)and NT-proBNP(HR=1.001,95%CI:1.000-1.010,P<0.001)were independent predictors of MACE.According to the statistical analysis of ROC and Delong test,the AUC of combined sST2 and NT-proBNP in predicting MACE was 0.854,the sensitivity was 64.5%,the specificity was 93.1%,and the combined prediction of prognosis was better than that of individual prediction,with statistically significant difference(Z=2.119,P=0.034;Z=2.178,P=0.029).Conclusions:Serum sST2 and NT-proBNP are valuable predictors of MACE after emergency PCI in patients with STEMI,and the predictive efficacy increases with combined assessment of both sST2 and NT-proBNP.

soluble growth stimulation expressed gene 2 proteinmyocardial infarctionN-terminal pro-brain natriuretic peptidemajor adverse cardiac event

杨九月、常淑敏、孙溢晗、于倩、陈贵铭、包文奇、侯爱洁

展开 >

中国医科大学人民医院辽宁省人民医院心内科,沈阳 110016

中国医科大学人民医院辽宁省人民医院胸外科,沈阳 110016

可溶性生长刺激表达基因2蛋白 心肌梗死 N末端B型利钠肽原 主要不良心血管事件

2024

中国循环杂志
中国医学科学院

中国循环杂志

CSTPCD北大核心
影响因子:2.803
ISSN:1000-3614
年,卷(期):2024.39(6)